🔗 Share this article

An underground market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Treatment Acquiring Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these profiles privately for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where groups with thousands of members share comparison photos, administration instructions and assertions of rapid British shipping. Vendors market the drug there before directing customers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.

Some professionals said the demand for the experimental drug could be linked to the rising cost of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Service Response and Material Removal

According to TikTok, the service has taken down problematic material and prohibited associated hashtags and search suggestions. The company said it was dedicated to keeping the platform secure and allocating resources in enhancing compliance measures.

Digital Trading Activities

Research also discovered communities with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately displays groups with numerous of users, filled with photos of weight loss, positive testimonials and step-by-step instructions for preparing or injecting at residence.

Within minutes of entering one community, a seller posted WhatsApp details, where most transactions take place. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.

Product Details and Costs

Within these groups, messages show dark colored parcels with postal service stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for the messaging service said it actively monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is valid, these online versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are using social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has already seen patients injured by personal administration from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Producer Position

A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet authorized … may expose users to possibly serious medical dangers”.